loadpatents
name:-0.0096421241760254
name:-0.014345169067383
name:-0.00049304962158203
Wilson; William Robert Patent Filings

Wilson; William Robert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wilson; William Robert.The latest application filed is for "kinase inhibitors, prodrug forms thereof and their use in therapy".

Company Profile
0.12.16
  • Wilson; William Robert - Waiuku NZ
  • Wilson; William Robert - Waluki NZ
  • Wilson; William Robert - Auckland NZ
  • Wilson, William Robert - Queensland AU
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Kinase Inhibitors, Prodrug Forms Thereof And Their Use In Therapy
App 20160031877 - Smaill; Jeffrey Bruce ;   et al.
2016-02-04
Prodrug Forms Of Kinase Inhibitors And Their Use In Therapy
App 20160002222 - Smaill; Jeffrey Bruce ;   et al.
2016-01-07
Kinase inhibitors, prodrug forms thereof and their use in therapy
Grant 9,101,632 - Smaill , et al. August 11, 2
2015-08-11
Prodrug forms of kinase inhibitors and their use in therapy
Grant 9,073,916 - Smaill , et al. July 7, 2
2015-07-07
Kinase Inhibitors, Prodrug Forms Thereof And Their Use In Therapy
App 20120202832 - Smaill; Jeffrey Bruce ;   et al.
2012-08-09
Prodrug Forms Of Kinase Inhibitors And Their Use In Therapy
App 20120077811 - Smaill; Jeffrey Bruce ;   et al.
2012-03-29
Tricyclic 1,2,4-triazine oxides and compositions for therapeutic use in cancer treatments
Grant 7,989,451 - Hay , et al. August 2, 2
2011-08-02
1,2,4-benzotriazine-1,4-dioxides
Grant 7,816,521 - Denny , et al. October 19, 2
2010-10-19
Nitroaniline-based alkylating agents and their use as prodrugs
Grant 7,776,924 - Denny , et al. August 17, 2
2010-08-17
Nitrobenzindoles and their use in cancer therapy
Grant 7,718,688 - Denny , et al. May 18, 2
2010-05-18
Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents
App 20100010094 - Denny; William Alexander ;   et al.
2010-01-14
Nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents
Grant 7,629,332 - Denny , et al. December 8, 2
2009-12-08
Tricyclic 1,2,4-Triazine Oxides and Compositions for Therapeutic Use in Cancer Treatments
App 20090186886 - Hay; Michael Patrick ;   et al.
2009-07-23
Nitrobenzindoles and Their use in Cancer Therapy
App 20080119442 - Denny; William Alexander ;   et al.
2008-05-22
Combination approaches to cancer treatment
App 20080064665 - Patterson; Adam Vorn ;   et al.
2008-03-13
Novel 1,2,4-benzotriazine-1,4-dioxides
App 20070197534 - Denny; William Alexander ;   et al.
2007-08-23
Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy
App 20070191372 - Brown; J. Martin ;   et al.
2007-08-16
Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents
App 20070032455 - Denny; William Alexander ;   et al.
2007-02-08
Anti-cancer 2,3-dihydro-1H-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium
Grant 7,064,117 - Denny , et al. June 20, 2
2006-06-20
Nitroaniline-based alkylating agents and their use as prodrugs
App 20050256191 - Denny, William Alexander ;   et al.
2005-11-17
Anti-cancer 2,3-dihydro-1H-pyrrole[3,2-f] quinoline compolexes of cobalt and chromium
App 20050038249 - Denny, William Alexander ;   et al.
2005-02-17
Benzoazine mono-N-oxides and benzoazine 1,4 dioxides and compositions therefrom for the therapeutic use in cancer treatments
App 20040192686 - Wilson, William Robert ;   et al.
2004-09-30
Anti-cancer 2,3-dihydro-1h-pyrrolo[3,2-f[quinoline complexes of cobalt and chromium
App 20040138195 - Denny, William Alexander ;   et al.
2004-07-15
Building frame bracing panel and method
App 20030101675 - Wilson, William Robert
2003-06-05
Enediyne compounds
Grant 6,124,310 - Denny , et al. September 26, 2
2000-09-26
Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents
Grant 5,872,129 - Denny , et al. February 16, 1
1999-02-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed